SK-MEL-1 Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | This cell line was established in 1966 by F. Oettgen and associates using cells from the thoracic duct of a patient. Pigment granules relating both to synthesis and to phagocytosis are present. According to our sequencing, WB and PCR results this cell line carries a BRAF V600E mutation. Cells are N-Ras wildtype. |
|---|---|
| Organism | Human |
| Tissue | Skin |
| Disease | Melanoma |
| Metastatic site | Thoracic lymph duct |
| Synonyms | SK-Mel-1, SK Mel 1, SK-Mel 1, SK-Mel1, SKMEL-1, SkMEL-1, SKMEL1, SK 1 |
Characteristics
| Age | 29 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Spherical |
| Growth properties | Suspension |
Regulatory Data
| Citation | SK-MEL-1 (Cytion catalog number 300424) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0068 |
Biomolecular Data
| Antigen expression | Blood Type A, Rh+. Antibody to this line was detected in 63% of patients with malignant melanoma and in 10% of patients with other diseases. |
|---|---|
| Isoenzymes | PGM3, 1, PGM1, 1, ES-D, 1, AK-1, 1, GLO-1, 1-2, G6PD, B, |
| Tumorigenic | Yes, in nude mice. Forms pigmented malignant melanomas. Also forms tumors in the cheek pouch of cortisone treated hamsters |
| Products | Melanin |
| Mutational profile | V600E type BRAF Mutation was determined by DNA based methods (sequencing, RT-PCR) and protein based methods (Western Blot) |
Handling
| Culture Medium | RPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 15% heat-inactivated FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Seeding density | 1 to 2 x 105 cells/mL |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300424-271025 | Certificate of Analysis | 05. Dec. 2025 | 300424 |
| 300424-812 | Certificate of Analysis | 23. May. 2025 | 300424 |